©PPRNet 2014 NEW PROJECT Reducing ADEs from Anticoagulants, Diabetes Agents and Opioids in Primary Care.

Slides:



Advertisements
Similar presentations
Care Transitions – Critical to Quality and Patient Safety Society of Hospital Medicine Lakshmi K. Halasyamani, MD.
Advertisements

©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
1 Wisconsin Partnership Program Steven J. Landkamer Program Manager Wisconsin Dept. of Health & Family Services July 14, 2004.
David Garr, MD Executive Director South Carolina Area Health Education Consortium Associate Dean for Community Medicine Medical University of South Carolina.
MS-TRIP 2: Disseminating the PPRNet Model for Improving Medication Safety Andrea Wessell, PharmD Lynne Nemeth, PhD, RN AHRQ Grant Number 1 R18HS
©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
1 The role of CQC – changes to regulation. 2 Our purpose and role Our purpose We make sure health and social care services provide people with safe, effective,
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Questions or comments on this presentation can be addressed to You can pick and choose the elements.
PCP Capacity Study Regional Findings Commissioned by the Executive Stakeholders’ Council.
Texas Diabetes Education & Care Management Project Funded by Bristol-Myers Squibb Foundation Bureau of Primary Health, HRSA CDC Diabetes Prevention (in-kind.
Frail Older People Co Chairs Maura Devlin and Dr April Heaney Engagement through a workshop with a wide range of stakeholders Key priorities areas identified.
Basics: 2As & R Clinical Intervention Artwork by Nancy Z. © 2010 American Aca0emy of Pediatrics (AAP) Children's Art Contest. Support for the 2010 AAP.
[Hospital Name | Presenter name and title | Date of presentation]
Engaging the C-suite to Advance Pharmacy Practice Providing quality patient care through progressive pharmacy practice Evaluation of Unit-based Pharmacy.
Key Findings : Paying for Self-Management Supports as Part of Integrated Community Health Care Systems July, 2012.
MaineHealth ACO in Context W 5 Who? What? Why? When? HoW? 1.
Using Outreach & Enabling Services to Support the Goals of a Patient-Centered Medical Home Oscar C. Gomez, CEO Health Outreach Partners Health Resources.
Leadership and Management Training for physicians Maria V. Gibson, MD, PhD Trident / MUSC Family Medicine Residency Program Background Practice Problem.
Presented by Vicki M. Young, PhD October 19,
Strategy and Innovation Workgroup: Recommendations on the Federal Health IT Strategic Plan March 4, 2015 David Lansky, Chair Jennifer Covich,
© 2012, The Brookings Institution Current Directions in Quality Measurement Barbara Gage, PhD Fellow, Engelberg Center for Health Care Reform at Brookings.
Inquiry process 4 panellists and 3 professional advisers Evidence briefing Written submissions from organisations Oral evidence sessions Professional.
Darren A. DeWalt, MD, MPH Division of General Internal Medicine Maihan B. Vu, Dr.PH, MPH Center for Health Promotion and Disease Prevention University.
Perspectives on the Age Wave: Key Issues, Solutions, and Opportunities Robyn Golden, LCSW Director of Older Adult Programs Rush University Medical Center.
Nelly Burdette, Psyd Director, Integrated Behavioral Health, PCHC Integrated Behavioral Health Practice Facilitator, CTC MHI Faculty Advisor, HMS Center.
An Integrated Healthcare System’s Approach to ACOs Chuck Baumgart, M.D., Chief Medical Officer Presbyterian Health Plan David Arredondo, M.D., Executive.
Big Strides for Small Patients: Developmental Screening in Pediatric Primary Care Department of Pediatrics Jerold Stirling, MD Rebecca Turk, MD Melanie.
Care Transitions in Georgia: Partnering with your community to move readmissions Jennifer Hodge RN MSBA Aim Lead, Integrating Care for Populations Communities.
IMPROVING DIABETES MANAGEMENT IN PRIMARY CARE
Basma Y. Kentab MSc.. 1. Define ambulatory care 2. Describe the value of ambulatory care practices 3. Explore pharmacy services in some ambulatory care.
TRANSITION PLAN STAKEHOLDER GROUP CENTER FOR DEAF AND HARD OF HEARING EDUCATION.
© 2013 sanofi-aventis U.S. LLC, A SANOFI COMPANY All rights reserved Printed in the USA US.NMH Do not copy. Do not distribute. Do not leave behind.
SIM- Data Infrastructure Subcommittee November 14, 2013.
Education & Training Curriculum on Multiple Chronic Conditions (MCC) Strategies & tools to support health professionals caring for people living with MCC.
Accreditation Canada Critical care team By Norah Khathlan MD Assistant Prof. Pediatrics Consultant Pediatric Intensivist Director PICU January/ 2009.
United Regional Diabetes Education Laura Gutierrez, R.N. CDE Diabetes Education Manager.
AHRQ’s Safety Program for Nursing Homes: On-Time Pressure Ulcer Prevention Facilitator Training Overview of On-Time.
November 18, 2014 Connecticut State Innovation Model Initiative Presentation to the Health Care Cabinet.
School of SOCIAL AND COMMUNITY MEDICINE University of BRISTOL Shall we meet for coffee? Experiments in ways of bridging the researcher commissioner gap:
Supporting and Engaging Consumers PCPCC Annual Summit: All eyes on the PCMH Shannah Koss, Koss on Care LLC October 22, 2009.
Children’s Mental Health Plan Advisory Committee Meeting June 17, 2014.
Care Management 101 Governor's Office of Health Care Reform October 28, 2010 Cathy Gorski, RN, BS, CCM.
Teaching Health Professionals How to Treat Type 2 Diabetes Jennifer Larsen, MD Professor and Chief, DEM, University of Nebraska Medical Center.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
Staff Physician & Resident Physician Toolkit
Multidisciplinary Diabetes Team Activities in a 196 Bed Community Hospital Robin Southwood, Pharm.D, CDE and Beth Melvin, RD, MS, CDE.
1 Strategic Plan Review. 2 Process Planning and Evaluation Committee will be discussing 2 directions per meeting. October meeting- Finance and Governance.
Pharmacists’ Patient Care Process
Making It Better Planning Employee & Patient Satisfaction November 2010.
Development of a Diabetes Transition Program at the Medical University of South Carolina SCTR Scientific Retreat on Transition of Care Across the Lifespan.
Transforming Care in Patient Centered Medical Home and Accountable Care Organization Hae Mi Choe, PharmD Director, Pharmacy Innovations & Partnerships.
Coquille Indian Tribe Health and Human Services. MISSION We foster and promote a whole person approach to wellness, health and the promotion of self sufficiency.
Putting Patients at the Centre of Care What can my Community Pharmacist do for me? Dr Tarlochan Gill Chairman, Kent & Medway Pharmacy Local Professional.
AACN – Manatt Study In February 2015, the AACN Board of Directors commissioned Manatt Health to conduct a study on how to position academic nursing to.
Using PI Projects to Engage Residents in PCMH Transformation Kathleen Straubinger, RN, BSN Jeffrey Mathieu, MD STFM Practice Improvement November 2013.
Children’s Policy Conference Austin, TX February 24, ECI as best practice model for children 0-3 years with developmental delays / chronic identified.
Quality Improvement Projects: Utilizing the Power of Students in the Primary Care Setting Donald L. Clark, MD Wright State University Boonshoft School.
The Medicines Adherence and Waste Challenge Carol Roberts Director of Strategic Prescribing EAHSN and PrescQIPP.
Health Homes: SPA Application Process August 17, :00AM 1.
Clinical Project Meeting NYHQ PPS Delivery System Reform Incentive Payment (DSRIP) Home Health Collaborations (2bviii)
Improving Patient Outcomes in Diabetes Matt Petersen Managing Director, Medical Information & Professional Engagement American Diabetes Association.
Developing role of community pharmacy in responding to the needs of people with drug problems Karen Melville Principal Pharmacist TSMS NHS Tayside.
ADVERSE DRUG EVENT (ADE) Driver Diagram OHA HEN 2.0.
The Patient Centered Medical Home. Learning Objectives Identify the attributes of a patient centered medical home Describe some processes that facilitate.
The AHRQ Safety Program for Improving Antibiotic Use
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Patient Centered Medical Home
The AHRQ Safety Program for Improving Antibiotic Use
The AHRQ Safety Program for Improving Antibiotic Use
Presentation transcript:

©PPRNet 2014 NEW PROJECT Reducing ADEs from Anticoagulants, Diabetes Agents and Opioids in Primary Care

©PPRNet 2014 GOALS Present newly funded medication safety project Discuss opportunities for practice and patient involvement Plan your role in the project

©PPRNet 2014

WHY? High priority medications “ADEs across inpatient and outpatient settings are common, clinically signficant, preventable and measurable” –Anticoagulants –Diabetes agents –Opioids

©PPRNet 2014 Focus on high priority medications “…address the prevention of harm, but also promote standardized and idealized practices and behaviors” Include patients as a vital part of research Target ambulatory care Advancing Patient Safety Implementation through Safe Medication Use Research (PA )

©PPRNet 2014

TIMELINE June-July 2014 “Good” score Respond to criticisms January 25, 2014 Application submitted December 2013 – January 2014 Project planning Request letters of support November 2013 Funding Announcement posted

©PPRNet 2014 PROJECT GOALS 1)Clarify risk factors for ADEs from high priority medications through a literature review and translate them into a working set of clinical quality measures that can be implemented in primary care 2)Use a community engaged action (CEA) research approach to test the impact of a refined set of preventive strategies for ADEs on practice performance on ADE clinical quality measures

©PPRNet 2014 GOAL 1: DEVELOP ADE MEASURES Preliminary set of measures –Based on established risk factors –Include existing or proposed MU measures Existing Stage 2 MU measures Proposed Stage 3 MU measures Proposed by research team based on National Action Plan –Revise based on provider input during year 1

©PPRNet 2014 GOAL 1: PRELIMINARY MEASURES ADE Risk Factor Lack of safe prescribing and monitoring processes for new oral anticoagulants Example: Anticoagulants

©PPRNet 2014 GOAL 1: PRELIMINARY MEASURES ADE Risk FactorCQM Lack of safe prescribing and monitoring processes for new oral anticoagulants Patients on appropriate doses of new oral anticoagulants based on renal function Example: Anticoagulants

©PPRNet 2014 GOAL 1: PRELIMINARY MEASURES ADE Risk Factor Application of aggressive glycemic targets in high risk patients Example: Diabetes Agents

©PPRNet 2014 GOAL 1: PRELIMINARY MEASURES ADE Risk FactorCQM Application of aggressive glycemic targets in high risk patients Patients > 65 years with diabetes on sulfonylurea or insulin AND most recent A1C > 7% Patients with specific comorbidities* on sulfonylurea or insulin AND most recent A1C > 7% Example: Diabetes Agents

©PPRNet 2014 GOAL 1: PRELIMINARY MEASURES ADE Risk Factor Higher than recommended daily doses Example: Opioids

©PPRNet 2014 GOAL 1: PRELIMINARY MEASURES ADE Risk FactorCQM Higher than recommended daily doses Patients on recommended doses of long-term opioid therapy Example: Opioids

©PPRNet 2014 GOAL 1: MEASURE DEVELOPMENT ActivityTimeline Confirm participation of 24 practicesToday! Clarify ADE risk factorsOct 2014 Specify measuresDec 2014 Survey providers “Is this a useful measure of quality?” Open comments Early 2015

©PPRNet 2014 GOAL 2: TEST “COMMUNITY ENGAGED” APPROACH Practice community = patients or non-professional caregivers, clinical staff and providers Site visits and regular follow-up Purpose: –Academic detailing on ADE risk factors –Performance review and improvement planning –Practice-specific integration of strategies to prevent ADEs

©PPRNet 2014 YES, PATIENTS! Practice invites 9-12 patients or non- professional caregivers to participate –From PPRNet list of patients eligible for CQMs Ideal characteristics of “key informants” –Ability to communicate clearly –Interest in project goal –Willingness to participate in site visits –Together, represent diverse age groups, race/ethnicity, medications

©PPRNet 2014 Community Engaged Group (12 practices) Control Group (12 practices) Provider surveysXX Reports on ADE measuresXX Site visits with patient “key informants” X Regular follow-up via webinar/ X

©PPRNet 2014 WHAT IS REQUIRED OF PRACTICES? Open to all members! Submit PPRNet data extracts through Sept 2017 Complete two rounds of measure development survey Agree to invite patients to participate AND host 3 site visits if randomized to intervention

©PPRNet 2014 INCENTIVES TO PARTICIPATE Opportunity to define “meaningful” CQMs Facilitated PPRNet quality and safety improvement assistance Concrete example for PCMH “Patient Advisory Council” objective Financial incentives for practices ($1200 each + $800/intervention) and patient advisors ($25/activity)

©PPRNet 2014 LETTERS OF SUPPORT We received letters of support from 15 practices in attendance: Advanzed Health Care PLC Cayuga Family Medicine Dutter Hufford Daley MDs Family Medicine of Port Angeles Family Practice Associates, LLP Lovelace Family Medicine Northeast Iowa Medical Education Foundation Plymouth Family Physicians Quality Family Practice Ravalli Family Medicine Rio Grande Medicine Smoky Hill Family Medicine Residency Program Springfield Health Care Summit View Clinic The Internal Medicine and Pediatric Clinic of New Albany

©PPRNet 2014 IT’S NOT TOO LATE! Byron Center Family Medicine Chatuge Family Practice Clover Fork Clinic Diana Lozano, MD, PA Family Health Associates Fulton Family Health Associates Georgia Regents Family Medicine Center Good Samaritan Health Center of Cobb Hilliard Family Medicine Hugh D. Durrence, MD John A. Martin Primary Health Care Center Lake Lansing Family Practice Matthew White, MD Mt View Family Practice Natural Family Wellness New London Family Practice Robert E. Barnett, M.D. LLC Rio Grande Valley Adult and Internal Medicine Skyline Family Practice Sopris Medical Practice South Park Internal Medicine UT Health Systems

©PPRNet 2014 ARE YOU IN? Yes Yes, awaiting confirmation from the rest of my practice No because …

©PPRNet 2014

EXTRA SLIDES

©PPRNet 2014 WHY? Adverse drug events are “injuries from medical intervention related to a drug” Preventable ADEs could have been avoided or mitigated by hightened monitoring or more optimal care management

©PPRNet 2014 PROJECT OVERVIEW

©PPRNet 2014